Brookings, SD, United States of America

Hesham Fahmy

This inventor holds 1 USPTO granted patent. Top assignees: Case Western Reserve University, The University of Mississippi. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hesham Fahmy. Retrieved from https://idiyas.com/inventor/hesham-fahmy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Hesham Fahmy

Introduction

Hesham Fahmy is a notable inventor based in Brookings, SD (US). He has made significant contributions to the field of pharmacology, particularly through his innovative work on opioid receptor affinity. His research has implications for the development of new medicinal compounds.

Latest Patents

Hesham Fahmy holds a patent for "Agents with selective κ-opioid receptor affinity." This patent includes compounds and compositions that are derivatives of salvinorin A and salvinorin B. These derivatives demonstrate selectivity and potency for the k-opioid receptor (KOR), allowing for their use as medicines and as chemical probes in various fields utilizing radiolabeled binding assays. He has 1 patent to his name.

Career Highlights

Throughout his career, Fahmy has worked with prestigious institutions such as the University of Mississippi and Case Western Reserve University. His work has focused on advancing the understanding of opioid receptors and their potential therapeutic applications.

Collaborations

Hesham Fahmy has collaborated with notable researchers in his field, including Bryan Roth and Jordan K Zjawiony. These collaborations have further enriched his research and contributed to the advancement of knowledge in pharmacology.

Conclusion

Hesham Fahmy's innovative work in the field of opioid receptor affinity showcases his dedication to advancing medical science. His contributions have the potential to lead to significant advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…